Immuron LimitedIMRN
Key ratios
FCF / Sales
-42.3%TTM
2026
-42.3%2025
-84.2%2024
-119.9%
Net margin
-49.8%TTM
2026
-49.8%2025
-71.6%2024
-141.5%
ROA
-21.7%TTM
2026
-21.7%2025
-26.1%2024
-17.4%
ROE
-40.3%TTM
2026
-40.3%2025
-50.2%2024
-42.9%
Revenue growth
5.9%TTM
2026
5.9%2025
48.6%2024
171.7%
Recent news
Immuron CEO, Steven Lydeamore presentation at Emerging Growth Conference
Travelan Phase 2 Study Results Published
Track IMRN in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer